Heart failure is a costly, morbid condition that is estimated to affect approximately 6.2 million individuals in the United States at a cost of $30.7 billion, which is estimated to increase to $69.8 billion by 2030.1 African American individuals are disproportionately diagnosed with heart failure compared with white individuals. Overall, the incidence typically starts several decades earlier2 and is associated with greater morbidity and mortality in African American than white individuals.1 African American men have the highest age-adjusted death rate for heart failure (118.2 per 100 000), followed by non-Hispanic white men (111.3 per 100 000), African American women (86.0 per 100 000), and white women (80.4 per 100 000).1 After medical management is no longer effective, advanced therapies for heart failure, such as ventricular assist devices (VAD), improve quality of life and survival and can be used as terminal treatment or as a bridge to heart transplantation.1
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Young BA. Health Disparities in Advanced Heart Failure Treatment: The Intersection of Race and Sex. JAMA Netw Open. 2020;3(7):e2011034. doi:10.1001/jamanetworkopen.2020.11034
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: